OpenURL Connection Search

Select item for more details and to access through your institution.

Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2087, doi. 10.1007/s00262-023-03394-7
By:
- Nagato, Toshihiro;
- Komatsuda, Hiroki;
- Hayashi, Ryusuke;
- Takahara, Miki;
- Kishibe, Kan;
- Yasuda, Shunsuke;
- Yajima, Yuki;
- Kosaka, Akemi;
- Ohkuri, Takayuki;
- Oikawa, Kensuke;
- Harabuchi, Shohei;
- Kono, Michihisa;
- Yamaki, Hidekiyo;
- Wakisaka, Risa;
- Hirata-Nozaki, Yui;
- Ohara, Kenzo;
- Kumai, Takumi;
- Katada, Akihiro;
- Hayashi, Tatsuya;
- Harabuchi, Yasuaki
Publication type:
Article
Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 989, doi. 10.1007/s00262-020-02524-9
By:
- Ohara, Mizuho;
- Ohara, Kenzo;
- Kumai, Takumi;
- Ohkuri, Takayuki;
- Nagato, Toshihiro;
- Hirata-Nozaki, Yui;
- Kosaka, Akemi;
- Nagata, Marino;
- Hayashi, Ryusuke;
- Harabuchi, Shohei;
- Yajima, Yuki;
- Oikawa, Kensuke;
- Harabuchi, Yasuaki;
- Sumi, Yasuo;
- Furukawa, Hiroyuki;
- Kobayashi, Hiroya
Publication type:
Article
Response to PD‐1 blockade in a patient with mucosal melanoma of the middle ear: Case report.
Published in:
Clinical Case Reports, 2020, v. 8, n. 12, p. 3468, doi. 10.1002/ccr3.3424
By:
- Komatsuda, Hiroki;
- Kumai, Takumi;
- Ueda, Seigo;
- Hirata‐Nozaki, Yui;
- Hayashi, Tatsuya;
- Harabuchi, Yasuaki
Publication type:
Article
A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy.
Published in:
Cancer Science, 2021, v. 112, n. 7, p. 2705, doi. 10.1111/cas.14973
By:
- Kosaka, Akemi;
- Yajima, Yuki;
- Hatayama, Mayumi;
- Ikuta, Katsuya;
- Sasaki, Takaaki;
- Hirai, Noriko;
- Yasuda, Syunsuke;
- Nagata, Marino;
- Hayashi, Ryusuke;
- Harabuchi, Shohei;
- Ohara, Kenzo;
- Ohara, Mizuho;
- Kumai, Takumi;
- Ishibashi, Kei;
- Hirata‐Nozaki, Yui;
- Nagato, Toshihiro;
- Oikawa, Kensuke;
- Harabuchi, Yasuaki;
- Celis, Esteban;
- Okumura, Toshikatsu
Publication type:
Article
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
Published in:
2019
By:
- Hirata-Nozaki, Yui;
- Ohkuri, Takayuki;
- Ohara, Kenzo;
- Kumai, Takumi;
- Nagata, Marino;
- Harabuchi, Shohei;
- Kosaka, Akemi;
- Nagato, Toshihiro;
- Ishibashi, Kei;
- Oikawa, Kensuke;
- Aoki, Naoko;
- Ohara, Mizuho;
- Harabuchi, Yasuaki;
- Uno, Yuji;
- Takei, Hidehiro;
- Celis, Esteban;
- Kobayashi, Hiroya
Publication type:
journal article

Found: 5

Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.

Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer.

Response to PD‐1 blockade in a patient with mucosal melanoma of the middle ear: Case report.

A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy.

PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.